Cargando…
An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
Over the past two decades, there has been a notable rise in the use of antipsychotic drugs, as they are used to treat an increasing number of neuropsychiatric disorders. This rise has been led predominantly by greater use of the second generation antipsychotic (SGA) drugs, which have a low incidence...
Autores principales: | Wu, Claire, Yuen, Jessica, Boyda, Heidi N., Procyshyn, Ric M., Wang, Cathy K., Asiri, Yahya I., Pang, Catherine C. Y., Honer, William G., Barr, Alasdair M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177840/ https://www.ncbi.nlm.nih.gov/pubmed/25254366 http://dx.doi.org/10.1371/journal.pone.0107116 |
Ejemplares similares
-
Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
por: Boyda, Heidi N., et al.
Publicado: (2013) -
Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance
por: Boyda, Heidi N., et al.
Publicado: (2022) -
A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021) -
Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
por: Boyda, Heidi N., et al.
Publicado: (2020) -
Association between Serum Lipids and Antipsychotic Response in
Schizophrenia
por: Kim, David D., et al.
Publicado: (2019)